Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry
Alan Menter*, Diamant Thaçi, Jashin J. Wu, William Abramovits, Francisco Kerdel, Dilek Arikan, Dianlin Guo, Arijit Ganguli, Mareike Bereswill, Anne Camez, Wendell C. Valdecantos
*Korrespondierende/r Autor/-in für diese Arbeit
44
Link öffnet neuen Tab
Zitate (Scopus)